Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6526
    +0.0026 (+0.40%)
     

  • OIL

    82.76
    -0.05 (-0.06%)
     

  • GOLD

    2,336.60
    -1.80 (-0.08%)
     

  • Bitcoin AUD

    97,907.16
    -3,935.80 (-3.86%)
     

  • CMC Crypto 200

    1,359.63
    -22.94 (-1.66%)
     

  • AUD/EUR

    0.6082
    +0.0012 (+0.20%)
     

  • AUD/NZD

    1.0955
    +0.0014 (+0.13%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,096.23
    +55.85 (+0.69%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    17,986.40
    -102.30 (-0.57%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

LATAM Pain Management Drugs Market to Garner $3.38 Billion by 2027: Allied Market Research

Allied Market Research
·5-min read

Increase in incidences of chronic diseases, favorable regulatory scenario, and surge in the geriatric population drive the growth of the LATAM pain management drugs market. The market across Brazil held the lion’s share in 2019, accounting for nearly half of the market. As cough is a major symptom of Covid-19 infection, the demand for opioids has increased during the pandemic.

Portland, OR, Nov. 25, 2020 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the LATAM Pain Management Drugs Market was pegged at $2.68 billion in 2019, and is projected to reach $3.38 billion by 2027, growing at a CAGR of 3.5% from 2020 to 2027.

Download Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/7953?reqfor=covid

Increase in incidences of chronic diseases, favorable regulatory scenario, and surge in the geriatric population drive the growth of the LATAM pain management drugs market. However, availability of alternative therapies, drug exploitation, and patent expiration of prescription drugs hamper the market growth. On the contrary, advancements in drug development and untapped market in developing countries are expected to open new opportunities for the market growth in the future.

ADVERTISEMENT

Covid-19 Scenario:

  • As cough is a major symptom of Covid-19 infection, the demand for opioids has increased during the pandemic.

  • However, the increasing number of Covid-19 patients and shortage of pain management drugs due to a ban on international trade and prolonged lockdown resulted in a huge demand-supply gap.

  • Since the Covid-19 outbreak, the adoption of telemedicine has increased. This enabled patients to consult the doctor from home. This has increased the demand for pain management drugs significantly.

The LATAM pain management drugs market is divided on the basis of drug class, indication, and region. Based on drug class, the market is segmented into NSAIDs, anesthetics, anticonvulsants, anti-migraine drugs, antidepressant drugs, opioids, non-narcotics, and analgesics. The opioids segment dominated the market in 2019, accounting for around one-fourth of the market. However, the anti-migraine agents segment is expected to manifest the highest CAGR of 4.4% during the forecast period.

On the basis of indication, the market is classified into arthritic pain, neuropathic pain, cancer pain, chronic pain, post-operative pain, migraine, fibromyalgia, bone fracture, muscle sprain/strain, acute appendicitis, and other indications. The neuropathic pain segment held the largest share in 2019, contributing to nearly one-fifth of the market. However, the cancer pain segment is estimated to portray the highest CAGR of 4.6% during the forecast period.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/7953

The LATAM pain management drugs market is analyzed across several regions such as Brazil, Argentina, Colombia, Peru, Chile, Ecuador, Panama, and Rest of Latin America. The market across Brazil held the lion’s share in 2019, accounting for nearly half of the market. However, the market across Argentina is expected to register the highest CAGR of 4.3% from 2020 to 2027.

The LATAM pain management drugs market report includes an in-depth analysis of the major market players such as Novartis AG, Eli Lilly & Company, Abbott Laboratories, Pfizer, Inc., Mylan NV., Merck & Co. Inc., Johnson & Johnson, and GlaxoSmithKline Plc.


Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.


Similar Reports:

Pain Management Drugs Market - Global Opportunity Analysis and Industry Forecast, 2020–2027

Topical Pain Relief Market - Global Opportunity Analysis and Industry Forecast, 2019-2027

Pain Management Devices Market - Global Opportunity Analysis and Industry Forecast, 2019-2027

Non-opioid Pain Patch Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Osteoarthritis Pain Drugs Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Veterinary Pain Management Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Topical Pain Relief Cream Market - Global Opportunity Analysis and Industry Forecast, 2019–2027


About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

CONTACT: Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research